The attributes of the DS or DP that are to be tested to obtain the necessary information about product quality safety and efficacy are determined during the Drug Development stage. The information ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
An overview of the validation and qualification requirements introduced in the 2022 EU GMP Annex 1 revision, with a focus on ...
Researchers from University Hospital Cologne have developed an autonomous agent-based AI system called ‘SPARK’ that acts as a “digital brain” / publication in ‘Nature Medicine’ The digital ...
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
In 2026, the intelligence community (IC) is facing an unprecedented challenge, and tactical-level intelligence ...
Global Immune Repertoire Sequencing Market OverviewThe global immune repertoire sequencing market is projected to expand at a steady compound annual growth rate of approximately 10% during the ...
From data quality and AI readiness to the realities of clinical translation, industry leaders share where precision still ...
In an industry often driven by speed and spectacle, Szilard Szurdok stands out for building something deeper — a model of ...
Camilla Liscio from Da Vinci Laboratory Solutions, UK discusses hert talk at HTC-19, which will focus on the challlenges and ...
Tank cleaning in specialty chemical manufacturing isn’t just routine maintenance. It directly affects product quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results